A 15-year-old who invented soap for skin cancer and World Central Kitchen (WCK), an organisation that has been feeding <a target=_blank href=https ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...

About the program: Project Equity is a 2021 initiative launched by the FDA's Oncology Center of Excellence to ensure that ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

Received supportive FDA feedback on key elements of the potential ELI-002 Phase 3 study design, including dose, schedule, ...

Yes. The FDA said it is banning the use of Red Dye No. 3 due to evidence that the synthetic color additive can cause cancer in animals. But the additive will still be present in some foods sold in ...

The FDA has banned the synthetic dye Red No. 3, used in over 9,200 food items such as candy, cakes, cookies, and certain drugs, due to its cancer risk. Despite banning Red No. 3, other artificial ...

Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy. The Food and Drug Administration (FDA) has approved Datroway (datopotamab ...

It belongs to a class of medicines called antibody-drug conjugates (ADCs), also known as "guided-missiles" because they are designed to target only cancer cells while sparing healthy cells ...

The FDA approved sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer. The agency also approved acalabrutinib as part of combination therapy for mantle cell lymphoma. The FDA ...